Adanna Akujuo, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Charlottesville, VANPI 1114188117
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (57.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Atricure, Inc. at 59.8% of the total. Reporting peaked in 2021 at $9,389 and has fallen 95.4% since, to $434 in 2025.
Across 69 payments — averaging $234.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$10K
- Edwards Lifesciences$4K
- Abiomed$1K
- Medtronic$392
- Abbott$222
- W. L. Gore & Associates, Inc.$195
- plus $633 from 14 others
What the payments were for
- Grants$9,27257%
- Travel & lodging$2,88118%
- Food & beverage$4,00825%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 8 | $9,667 |
| Edwards Lifesciences | 7 | $3,745 |
| Abiomed | 12 | $1,307 |
| Medtronic(2 entities) | 9 | $392 |
| Abbott | 8 | $222 |
| W. L. Gore & Associates, Inc. | 1 | $195 |
| Angiodynamics, Inc. | 1 | $120 |
| La Jolla Pharmaceutical Company | 2 | $116 |
| Boston Scientific | 1 | $89 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $55 |
| Boehringer Ingelheim | 2 | $48 |
| Chiesi USA, Inc. | 2 | $41 |
| Pfizer | 3 | $36 |
| Kls-martin L.p. | 2 | $32 |
| Baxter Healthcare | 2 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Gilead | 1 | $18 |
| Amgen | 1 | $14 |
| Portola Pharmaceuticals, LLC | 1 | $11 |
| Intuitive Surgical | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNERGY ABLATION SYSTEM$9,272
- Impella$797
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$195
- Simulus$143
- AngioVac$120
- Avalus$115
- GIAPREZA$112
How this compares
$16,161 in reported general payments places this provider in the 75th percentile of 109 thoracic surgery (cardiothoracic vascular surgery) providers in Virginia.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 11 | $74 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Charlottesville
- Linda MartinCharlottesville$76K
- Kim de la CruzCharlottesville$34K
- Leora YarboroCharlottesville$27K
- Walker JulliardCharlottesville$15K
- Mary Carolyn VinsonCharlottesville$8K
- Philip CarrottCharlottesville$6K
- Jared BellerCharlottesville$5K
- Erik ScottCharlottesville$4K
- Clinton KempNorfolk$367K
- Sandeep KhandharFairfax$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.